Earnings Feed
Start Free
Home/Filings/4/0001140361-10-008266
4//SEC Filing

Horowitz Helen 4

Accession 0001140361-10-008266

CIK 0001360530other
View on SEC.govCompany Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 9:06 PM ET

Size

51.4 KB

Accession

0001140361-10-008266

Insider Transaction Report

Form 4
Period: 2009-11-02
Vitamin Shoppe, Inc.VSI
Horowitz Jeffrey
10% Owner
Transactions
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total(indirect: See footnotes)
Horowitz Helen
10% Owner
Transactions
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
Jeffrey Horowitz April 1996 GRAT
10% Owner
Transactions
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
Helen Horowitz April 1996 GRAT
10% Owner
Transactions
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−1,593.77$2,759,119→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
  • Other

    Common Stock

    2009-11-02+35,800→ 35,800 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−139,582$2,372,894→ 0 total(indirect: See footnotes)
  • Sale

    Common Stock

    2009-11-02$17.00/sh−558,326$9,491,542→ 0 total
  • Other

    Common Stock

    2009-11-02+143,203→ 143,203 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
  • Sale

    Series A Preferred Stock

    2009-11-02$1731.19/sh−398.44$689,775→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total
  • Other

    Series A Preferred Stock

    2009-11-02−1,406.23→ 0 total(indirect: See footnotes)
  • Other

    Series A Preferred Stock

    2009-11-02−351.56→ 0 total(indirect: See footnotes)
Footnotes (8)
  • [F1]See Exhibit 99.1 for text of footnote 1.
  • [F2]See Exhibit 99.1 for text of footnote 2.
  • [F3]See Exhibit 99.1 for text of footnote 3.
  • [F4]See Exhibit 99.1 for text of footnote 4.
  • [F5]See Exhibit 99.1 for text of footnote 5.
  • [F6]See Exhibit 99.1 for text of footnote 6.
  • [F7]See Exhibit 99.1 for text of footnote 7.
  • [F8]See Exhibit 99.1 for text of footnote 8.

Documents

2 files

Issuer

Vitamin Shoppe, Inc.

CIK 0001360530

→
Entity typeother

Related Parties

1
  • filerCIK 0001485056

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 9:06 PM ET
Size
51.4 KB
View on SEC.gov